About Us

Company Profile

Culture

History

Honors

Hunan Xianshi Pharmaceutical Co., Ltd.

Hunan Xianshi Pharmaceutical Co., Ltd. is a modern, integrated pharmaceutical enterprise driven by innovation and focused on high-quality pharmaceutical products. We have built a complete value chain spanning APIs, formulations, and clinical applications. Committed to delivering high-quality solutions for public health, we strive to become a benchmark for innovative pharmaceutical companies that combine strong technical expertise with dynamic growth.
5 hundred million yuan

Investment scale

30000 +

Service-covered terminals

90 +

Supply Region

50 +

Honorary Patent

Real-life view of the factory office building

The company is located in the Liuyang Economic and Technological Development Zone, covering an area of 85 mu (approximately 5.7 hectares). It is a national high-tech enterprise and a "Little Giant" recognized for its niche specialization and innovation strength in Hunan Province. The company has established a provincial-level enterprise technology center occupying approximately 5,000 square meters, laying a solid foundation for independent R&D and technological innovation. Its production base comprises multiple manufacturing lines for active pharmaceutical ingredients (APIs), oral solid dosage forms (including tablets, granules, hard capsules, and soft capsules), oral liquid formulations, small-volume injectables, large-volume injectables, inhalation preparations, ophthalmic preparations, and Class III medical devices, achieving broad coverage across major dosage forms.

This has enabled the company to establish a fully integrated, vertically aligned operation—from self-sufficiency in API supply to formulation manufacturing—ensuring efficient and synergistic manufacturing operations.

Corporate culture

Corporate Values

First, serve others; in helping others, you also achieve your own success.

Corporate Vision

Leading the industry through innovation and winning the world with quality.

Code of Conduct

Delivering the right outcomes is the only way to earn compensation, and proposing solutions is a prerequisite for reporting on one’s work.

Quality Standards

Patient safety, quality first, professional dedication, and relentless pursuit of precision.

Corporate Vision

Leading the industry through innovation and winning the world with quality.

Code of Conduct

Delivering the right outcomes is the only way to earn compensation, and proposing solutions is a prerequisite for reporting on one’s work.

Quality Standards

Patient safety, quality first, professional dedication, and relentless pursuit of precision.

Development History

May 2026

Vonoprazan fumarate and avatrombopag maleate were both approved for marketing (transitioned to Category A status).

Nov 2025

Propacetamol hydrochloride inhalation solution, avatrombopag maleate tablets, and roxadustat capsules were successfully selected in the 11th round of national centralized drug procurement.

Nov 2025

Achieved commercial production and market launch for 16 varieties (28 specifications).

Oct 2024

Production center began independent commercial production.

Company formally entered an accelerated phase of integrated production and sales.

May 2024

Launched the first commercially produced contract-manufactured product.

Apr 2024

Obtained Type D Drug Production License.

Awarded the title of "Specialized, Refined, Distinctive, and Innovative SME" by Hunan Province.

Mar 2024

Obtained Type A and Type C Drug Production Licenses.

Feb 2024

Selected as a pilot enterprise for intelligent manufacturing in Changsha City.

Jun 2023

Granted marketing authorization for the first approved product, clindamycin phosphate injection (June 6, 2023).

May 2023

Completed the main structure of Phase I and put the administrative office building into use.

Awarded the National High-Tech Enterprise designation.

Mar 2022

Obtained Type B Drug Production License.

Dec 2021

Established the R&D center, covering research activities across APIs, chemical drug formulations, and Class III medical devices.

May 2021

Hunan Xianshi Pharmaceutical Co., Ltd. was officially incorporated.

Launched Phase I project in the Liuyang Economic and Technological Development Zone.

2016

Launched collaborative R&D projects with domestic research institutions.

Qualifications and Honors

National High-Tech Enterprise

National High-Tech Enterprise

Hunan Provincial Enterprise Technology Center

Hunan Provincial Enterprise Technology Center

Innovative Small and Medium-sized Enterprises in Hunan Province

Innovative Small and Medium-sized Enterprises in Hunan Province

Specialized, Sophisticated, and Novel Small and Medium-sized Enterprises in Hunan Province

Specialized, Sophisticated, and Novel Small and Medium-sized Enterprises in Hunan Province

Learn more +